Related Experiment Videos
A controlled trial of ambroxol in chronic bronchitis
G H Guyatt1, M Townsend, F Kazim
1Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
Chest
|October 1, 1987
Abstract:
Ambroxol is a mucolytic agent which is widely used in chronic bronchitis in Europe. We conducted a double-blind randomized controlled trial of ambroxol vs matched placebo in 90 patients with chronic bronchitis and difficulty clearing secretions. It was concluded that there was no advantage to taking ambroxol.